AMY GALVAN: Open Payments
NPI 1326447400 · MCALLEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$389 in 11 payments from 8 companies in 2025. Trend: 2023 $46 · 2024 $28 · 2025 $389
Food & beverage: $389
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 2 | $211 |
| Lilly USA, LLC | 2 | $46 |
| Novo Nordisk Inc | 2 | $37 |
| ABBVIE INC. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| Amgen Inc. | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
Products named: FREESTYLE LIBRE 3, JARDIANCE, QULIPTA, XHANCE, OTEZLA, Rybelsus, Wegovy, XIFAXAN.
Industry payments across TX — which companies pay providers there.
